AG真人官方

BioLife Solutions (NASDAQ: BLFS), un'azienda leader nello sviluppo e fornitura di prodotti e servizi per la bioproduzione nel mercato della terapia cellulare e genica, ha annunciato la sua partecipazione a cinque conferenze per investitori previste per maggio e giugno 2025. La societ脿 sar脿 presente al Craig-Hallum Institutional Investor Conference (28 maggio, Minneapolis), al Benchmark Healthcare House Call Virtual Conference (29 maggio), al Jefferies Global Life Sciences Conference (3-5 giugno, New York), al Wolfe Research Small & Mid-Cap Conference (5 giugno, New York) e al Northland Growth Conference (25 giugno, virtuale).

BioLife Solutions (NASDAQ: BLFS), un desarrollador y proveedor l铆der de productos y servicios de bioproducci贸n para el mercado de terapias celulares y g茅nicas, ha anunciado su participaci贸n en cinco conferencias para inversores que se celebrar谩n en mayo y junio de 2025. La compa帽铆a asistir谩 a la Craig-Hallum Institutional Investor Conference (28 de mayo, Minneapolis), la Benchmark Healthcare House Call Virtual Conference (29 de mayo), la Jefferies Global Life Sciences Conference (3-5 de junio, Nueva York), la Wolfe Research Small & Mid-Cap Conference (5 de junio, Nueva York) y la Northland Growth Conference (25 de junio, virtual).

BioLife Solutions (NASDAQ: BLFS)電� 靹疙彫 氚� 鞙犾爠鞛� 旃橂�� 鞁滌灔鞚� 鞙勴暅 氚旍澊鞓れ儩靷� 鞝滍拡 氚� 靹滊箘鞀るゼ 臧滊皽路瓿店笁頃橂姅 靹犽弰 旮办梾鞙茧��, 2025雲� 5鞗旉臣 6鞗旍棎 鞐措Μ電� 雼れ劘 臧滌潣 韴�鞛愳�� 旎�韻茧煱鞀れ�� 彀戈皜頃� 鞓堨爼鞛勳潉 氚滍憸頄堨姷雼堧嫟. 須岇偓電� Craig-Hallum Institutional Investor Conference(5鞗� 28鞚�, 氙鸽媹鞎犿彺毽�鞀�), Benchmark Healthcare House Call Virtual Conference(5鞗� 29鞚�), Jefferies Global Life Sciences Conference(6鞗� 3-5鞚�, 雺挫殨), Wolfe Research Small & Mid-Cap Conference(6鞗� 5鞚�, 雺挫殨), 攴鸽Μ瓿� Northland Growth Conference(6鞗� 25鞚�, 鞓�霛检��)鞐� 彀胳劃頃� 鞓堨爼鞛呺媹雼�.

BioLife Solutions (NASDAQ : BLFS), un acteur majeur dans le d茅veloppement et la fourniture de produits et services de bioproduction pour le march茅 des th茅rapies cellulaires et g茅niques, a annonc茅 sa participation 脿 cinq conf茅rences investisseurs pr茅vues en mai et juin 2025. La soci茅t茅 assistera 脿 la Craig-Hallum Institutional Investor Conference (28 mai, Minneapolis), 脿 la Benchmark Healthcare House Call Virtual Conference (29 mai), 脿 la Jefferies Global Life Sciences Conference (3-5 juin, New York), 脿 la Wolfe Research Small & Mid-Cap Conference (5 juin, New York) et 脿 la Northland Growth Conference (25 juin, virtuelle).

BioLife Solutions (NASDAQ: BLFS), ein f眉hrender Entwickler und Anbieter von Bioproduktionsprodukten und -dienstleistungen f眉r den Markt der Zell- und Gentherapie, hat seine Teilnahme an f眉nf bevorstehenden Investorenkonferenzen im Mai und Juni 2025 angek眉ndigt. Das Unternehmen wird an der Craig-Hallum Institutional Investor Conference (28. Mai, Minneapolis), der Benchmark Healthcare House Call Virtual Conference (29. Mai), der Jefferies Global Life Sciences Conference (3.-5. Juni, New York), der Wolfe Research Small & Mid-Cap Conference (5. Juni, New York) und der Northland Growth Conference (25. Juni, virtuell) teilnehmen.